Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)

SHA:688553 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,982	2,328	1,782	1,206	1,306	371.52
Trading Asset Securities	763.29	688.59	789.05	1,376	1,662	228
Cash & Short-Term Investments	2,745	3,017	2,572	2,582	2,968	599.52
Cash Growth	3.25%	17.32%	-0.40%	-13.01%	395.07%	37.15%
Accounts Receivable	56.46	55.55	55.95	42.83	11.87	13.18
Other Receivables	14.57	86.09	69.37	44.64	29.24	29.39
Receivables	71.03	141.64	125.31	87.48	41.11	42.56
Inventory	202.75	159.92	153.12	165.98	178.87	94.63
Prepaid Expenses	-	0	-	-	-	-
Other Current Assets	132.79	25.95	20.19	38	45.44	24.05
Total Current Assets	3,152	3,344	2,870	2,873	3,233	760.77
Property, Plant & Equipment	1,477	1,516	1,410	1,123	672.48	329.68
Long-Term Investments	89.66	89.66	155.4	99.31	54.3	-
Other Intangible Assets	60.28	60.57	62.09	63.51	64.01	36.23
Long-Term Deferred Tax Assets	39.35	24.47	53.81	29.63	10.55	5.84
Long-Term Deferred Charges	31.78	26.78	17.96	1.61	-	-
Other Long-Term Assets	99.96	103.32	115.78	85.94	94.71	80.22
Total Assets	4,949	5,166	4,686	4,277	4,130	1,213
Accounts Payable	160.23	197.03	133.89	95.52	59.25	29.51
Accrued Expenses	28	235.4	215.31	47.87	289.79	232.39
Short-Term Debt	410.34	589.08	426.73	45.04	13.66	-
Current Portion of Leases	1.65	1.64	2.85	5.43	3.06	-
Current Income Taxes Payable	4.84	0.24	11.98	1.27	10.62	31.56
Current Unearned Revenue	65	54.33	27.03	36.87	35.65	22.46
Other Current Liabilities	254.54	59.03	61.52	294.39	80.88	81.2
Total Current Liabilities	924.6	1,137	879.32	526.39	492.91	397.12
Long-Term Leases	-	-	2.05	4.62	3.28	-
Long-Term Unearned Revenue	73.87	48.98	24.3	22.15	24.21	14.12
Long-Term Deferred Tax Liabilities	4.88	6.52	5.54	5.27	0.6	-
Other Long-Term Liabilities	-	-	-	-	50.02	50.02
Total Liabilities	1,003	1,192	911.22	558.44	571.01	461.26
Common Stock	423.6	423.6	423.6	423.6	423.6	360
Additional Paid-In Capital	2,487	2,487	2,485	2,474	2,473	175.54
Retained Earnings	1,081	1,106	870.83	830.55	670.94	225.08
Treasury Stock	-30.02	-30.02	-	-	-	-
Comprehensive Income & Other	-8.84	-8.24	-9.15	-9.63	-9.41	-9.14
Total Common Equity	3,953	3,979	3,771	3,718	3,558	751.48
Minority Interest	-6.72	-5.66	3.83	-	-	-
Shareholders' Equity	3,946	3,973	3,774	3,718	3,558	751.48
Total Liabilities & Equity	4,949	5,166	4,686	4,277	4,130	1,213
Total Debt	411.99	590.72	431.63	55.09	20	-
Net Cash (Debt)	2,333	2,426	2,140	2,527	2,948	599.52
Net Cash Growth	11.50%	13.38%	-15.31%	-14.29%	391.73%	50.98%
Net Cash Per Share	5.50	5.74	5.05	5.99	7.93	1.66
Filing Date Shares Outstanding	421.46	421.46	423.6	423.6	423.6	360
Total Common Shares Outstanding	421.46	421.46	423.6	423.6	423.6	360
Working Capital	2,227	2,208	1,991	2,347	2,741	363.64
Book Value Per Share	9.38	9.44	8.90	8.78	8.40	2.09
Tangible Book Value	3,893	3,918	3,709	3,655	3,494	715.25
Tangible Book Value Per Share	9.24	9.30	8.75	8.63	8.25	1.99
Buildings	-	654.99	315.19	179.43	127.91	127.91
Machinery	-	648.03	574.16	436.3	323.89	239.44
Construction In Progress	-	528.71	768.43	695.81	365.65	81.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.